Select a categories

  • Select a categories
  • PHYTODYNAMIC CANNABINOID PRODUCTS
  • Foodstuffs
  • Cannabinoid Foods
  • Traditional Hemp Foods
  • Consumer goods
  • Footwear
  • Children's shoes
  • Men's footwear
  • Women's shoes
  • Сlothing
  • Bed linen sets
  • Fiber
  • Hemp fabric
  • Women's hemp bag
  • Insoles
  • Hats
  • Knitwear
  • Cosmetics
  • Series "HEMP OIL"
  • Series "PHYTODYNAMIC CANNABINOID COSMETICS"
  • Supplies
  • Medicine
  • Information sources
  • Books
  • lm
  • Presentations

  • Your shopping cart is empty!

Compare 0

Israeli cabinet approved export of medical cannabis

30/01/2019 | hempmarket
heading_title

Exporting medical cannabis gives the state a huge advantage in combining research and development in the field of cannabis with agricultural enterprises and industry, aimed at processing therapeutic hemp. This type of business will bring significant revenues in foreign currency to the state and will maximize the benefits Israel possesses along the entire length of the established production chain from growing and processing therapeutic cannabis - to patients using cannabis for medical purposes. 

After the adoption of the relevant law by the Knesset in December 2018, on January 27, the Israeli Cabinet approved the rules allowing export of medical cannabis. This decision makes Israel one of the countries in an extremely narrow circle of exporters of therapeutic cannabis - the Netherlands, Canada, and the United Kingdom. According to the information of consulting agencies that study in detail the export potential of the medical cannabis market, in 2017 its volume was $ 8.3 billion, and by 2024 it will increase to $ 28 billion. 

The country's finance minister, Moshe Kahlon, claims that “all the time he supported the need to create conditions for the export of medical cannabis from Israel and welcomes this kind of government decision. Exporting medical cannabis gives the state a huge advantage in combining research and development in the field of cannabis with agricultural enterprises and industry, aimed at processing therapeutic hemp. This type of business will bring significant revenues in foreign currency to the state and maximize the benefits that Israel has throughout the entire established production chain from growing and processing therapeutic cannabis - to patients using cannabis for medical purposes.

Agriculture Minister Uri Ariel told the media that the cabinet decision sends the appropriate “historical message to Israeli farmers, processors, patients using cannabinoid medicine, and the entire economy of the country.” January 28, the head of the Israeli company  InterCure  Ehud Barak announced plans to start work in 10 countries during 2019-2020.

Commentary of the Association "Ukrainian technical hemp"

The system of legal cultivation and processing of psychoactive cannabis in Israel has been established and controlled by the Ministry of Agriculture since 2017. The relevant government committee approved a plan for the transition to the legal export of therapeutic cannabis outside of Israel in 2017. Export licenses will be provided by the country's ministry of health. Currently, 25,000 Israelis have received a license for the legal use of therapeutic cannabis, which has been law in Israel since the early 1990s. 

Israeli company Tikun Olam (MOT), founded in 2007, is still the largest legal psychoactive cannabis production company in the country, which expanded to Canada in 2014, when it became a partner of MedReleaf. In 2016, TO founded the company Tikun Olam USA, and in 2018 opened its unit in the UK.